Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
AIDS Malignancy Consortium
City of Hope Medical Center
Boston Medical Center
National Cancer Institute (NCI)
HemaQuest Pharmaceuticals Inc.
HemaQuest Pharmaceuticals Inc.